After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
IART belongs to the Healthcare sector of the NASDAQ while operating in the Medical Devices industry. The current market capitalization of Integra Lifesciences Holdings Corp is $1.74B. A total of 1.86 million shares were traded on the day, compared to an average of 581.39K shares.
Insider Activity
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, IART has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Schwartz Eric sold 4,070 shares of IART for 24.59 per share on Dec 03 ’24. After the transaction, the EVP, Chief Legal Officer & Sec now owns 59,511 company shares. In a previous transaction on Dec 03 ’24, Schwartz Eric bought 4,070 shares at 24.59 per share.
Among the insiders who sold shares, McBreen Michael J. disposed of 1,700 shares on Dec 02 ’24 at a per-share price of $24.16. This resulted in the EVP & President, CSS holding 56,182 shares of IART after the transaction. In another insider transaction, Mosebrook Jeffrey sold 1,191 shares at $21.58 per share on Aug 19 ’24. Company shares held by the SVP, Fin & Princ Acct Officer now total 36,088.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for IART in the last 3 months, the mean price target is $26.25 with high estimates of $35.00 and low estimates of $20.00. In terms of 52-week highs and lows, IART has a high of $40.92 and a low of $16.81.
As of this writing, IART has an earnings estimate of $0.43 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of $0.45 per share and a lower estimate of $0.41.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. IART’s latest balance sheet shows that the firm has $513.45M in Cash & Short Term Investments as of fiscal 2021. There were $1.65B in debt and $340.02M in liabilities at the time. Its Book Value Per Share was $20.03, while its Total Shareholder’s Equity was $1.68B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IART is Buy with a score of 2.82.
